Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 840921, 8 pages
http://dx.doi.org/10.1155/2014/840921
Research Article

Analysis of Differential miRNA Expression in Primary Tumor and Stroma of Colorectal Cancer Patients

1Department of Clinical Medicine and Surgery, University Federico II, Via Sergio Pansini 5, 80131 Napoli, Italy
2Department of Biology, University of Padova, Via 8 Febbraio 2, 35122 Padova, Italy
3Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milano, Italy
4Department of Public Health, University Federico II, Via Sergio Pansini 5, 80131 Napoli, Italy
5Department of Medicine, University of Salerno, Via Salvatore Allende 43, 84084 Baronissi, Italy

Received 27 February 2014; Revised 13 May 2014; Accepted 27 May 2014; Published 10 July 2014

Academic Editor: Kostas Iatrou

Copyright © 2014 Giuseppina Della Vittoria Scarpati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Dalmay and D. R. Edwards, “MicroRNAs and the hallmarks of cancer,” Oncogene, vol. 25, no. 46, pp. 6170–6175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Fu, Y. Han, Y. Wu et al., “Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis,” European Journal of Clinical Investigation, vol. 41, no. 11, pp. 1245–1253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. He, F. Zhang, Y. Wu et al., “Prognostic role of microRNA-155 in various carcinomas: results from a meta-analysis,” Disease Markers, vol. 34, no. 6, pp. 379–386, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Hong, J. Yang, Y. Han, Q. Lu, J. Cao, and L. Syed, “High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis,” Gene, vol. 507, no. 2, pp. 135–138, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Motoyama, H. Inoube, Y. Takatsuno et al., “Over- and under-expressed microRNAs in human colorectal cancer,” International Journal of Oncology, vol. 34, no. 4, pp. 1069–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Slaby, M. Svoboda, J. Michalek, and R. Vyzula, “MicroRNAs in colorectal cancer: translation of molecular biology into clinical application,” Molecular Cancer, vol. 8, article 102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Agostini, S. Pucciarelli, F. Calore, C. Bedin, M. Enzo, and D. Nitti, “miRNAs in colon and rectal cancer: a consensus for their true clinical value,” Clinica Chimica Acta, vol. 411, no. 17-18, pp. 1181–1186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Liu and H. Chen, “The role of microRNAs in colorectal cancer,” Journal of Genetics and Genomics, vol. 37, no. 6, pp. 347–358, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. L. Oberg, A. J. French, A. L. Sarver et al., “MiRNA expression in colon polyps provides evidence for a multihit model of colon cancer,” PLoS ONE, vol. 6, no. 6, Article ID e20465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. X. Zhang, W. Song, Z. H. Chen et al., “Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis,” The Lancet Oncology, vol. 14, no. 13, pp. 1295–1306, Dec 2013. View at Publisher · View at Google Scholar
  13. T. Schepeler, J. T. Reinert, M. S. Ostenfeld et al., “Diagnostic and prognostic microRNAs in stage II colon cancer,” Cancer Research, vol. 68, no. 15, pp. 6416–6424, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. H. Chang, N. Miller, E. A. Kheirelseid et al., “MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease,” International Journal of Colorectal Disease, vol. 26, no. 11, pp. 1415–1422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. H. Chen, S. W. Chang, C. C. Huang et al., “The prognostic significance of APC gene mutation and miR-21 expression in advanced-stage colorectal cancer,” Colorectal Disease, vol. 15, no. 11, pp. 1367–1374, 2013. View at Google Scholar
  16. M. Sund and R. Kalluri, “Tumor stroma derived biomarkers in cancer,” Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 177–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Kurose, K. Gilley, S. Matsumoto, P. H. Watson, X. Zhou, and C. Eng, “Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas,” Nature Genetics, vol. 32, no. 3, pp. 355–357, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. A. J. Trimboli, C. Z. Cantemir-Stone, F. Li et al., “Pten in stromal fibroblasts suppresses mammary epithelial tumours,” Nature, vol. 461, no. 7267, pp. 1084–1091, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Fukino, L. Shen, A. Patocs, G. L. Mutter, and C. Eng, “Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma,” The Journal of the American Medical Association, vol. 297, no. 19, pp. 2103–2111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Nishida, M. Nagahara, T. Sato et al., “Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters,” Clinical Cancer Research, vol. 18, no. 11, pp. 3054–3070, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Calura, R. Fruscio, L. Paracchini et al., “miRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities,” Clinical Cancer Research, vol. 19, no. 15, pp. 4114–4123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. A. Irizarry, B. M. Bolstad, F. Collin, L. M. Cope, B. Hobbs, and T. P. Speed, “Summaries of Affymetrix GeneChip probe level data,” Nucleic Acids Research, vol. 31, no. 4, article e15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. P. López-Romero, “Pre-processing and differential expression analysis of Agilent microRNA arrays using the AgiMicroRna Bioconductor library,” BMC Genomics, vol. 12, article 64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. G. K. Smyth, “Linear models and empirical Bayes methods for assessing differential expression in microarray experiments,” Statistical Applications in Genetics and Molecular Biology, vol. 3, no. 1, article 3, 2004. View at Publisher · View at Google Scholar · View at MathSciNet
  25. G. K. Smyth, “Limma: linear models for microarray data,” in Bioinformatics and computational biology solutions using R and bioconductor, R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, and W. Huber, Eds., pp. 397–420, Springer, New York, NY, USA, 2005. View at Google Scholar
  26. H. Shimodaira, “An approximately unbiased test of phylogenetic tree selection,” Systematic Biology, vol. 51, no. 3, pp. 492–508, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. E. L. Kaplan and P. Meier, “Nonparametric estimation for incomplete observations,” Journal of the American Statistical Association, vol. 53, pp. 457–481, 1958. View at Google Scholar
  28. S. D. Hsu, Y. T. Tseng, S. Shrestha et al., “miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions,” Nucleic Acids Research, vol. 42, no. D1, pp. D78–D85, 2014. View at Publisher · View at Google Scholar
  29. G. Sales, E. Calura, P. Martini, and C. Romualdi, “Graphite Web: Web tool for gene set analysis exploiting pathway topology,” Nucleic Acids Research, vol. 41, no. 1, pp. W89–W97, 2013. View at Publisher · View at Google Scholar
  30. D. W. Huang, B. T. Sherman, Q. Tan et al., “DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists,” Nucleic Acids Research, vol. 35, supplement 2, pp. W169–W175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. S. Mongroo and A. K. Rustgi, “The role of the miR-200 family in epithelial-mesenchymal transition,” Cancer Biology & Therapy, vol. 10, no. 3, pp. 219–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-M. Park, A. B. Gaur, E. Lengyel, and M. E. Peter, “The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2,” Genes & Development, vol. 22, no. 7, pp. 894–907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. Gregory, C. P. Bracken, E. Smith et al., “An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition,” Molecular Biology of the Cell, vol. 22, no. 10, pp. 1686–1698, 2011. View at Google Scholar
  34. A. Tsuchida, S. Ohno, W. Wu et al., “miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer,” Cancer Science, vol. 102, no. 12, pp. 2264–2271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. J. Braun, X. Zhang, I. Savelyeva et al., “p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest,” Cancer Research, vol. 68, no. 24, pp. 10094–10104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Meng, X. Fu, X. Chen et al., “miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice,” Hepatology, vol. 52, no. 6, pp. 2148–2157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Zhang, J. M. Liao, S. X. Zeng, and H. Lu, “P53 downregulates Down syndrome-associated DYRK1A through miR-1246,” EMBO Reports, vol. 12, no. 8, pp. 811–817, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Piepoli, F. Tavano, M. Copetti et al., “Mirna expression profiles identify drivers in colorectal and pancreatic cancers,” PLoS ONE, vol. 7, no. 3, Article ID e33663, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Ionescu, F. Dufrasne, M. Gelbcke, I. Jabin, R. Kiss, and D. Lamoral-Theys, “DYRK1A kinase inhibitors with emphasis on cancer,” Mini-Reviews in Medicinal Chemistry, vol. 12, no. 13, pp. 1315–1329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Tatarano, T. Chiyomaru, K. Kawakami et al., “Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines,” International Journal of Oncology, vol. 40, no. 4, pp. 951–959, 2012. View at Publisher · View at Google Scholar · View at Scopus